Patents Assigned to Cipla Ltd.
  • Patent number: 9403844
    Abstract: Amorphous rifaximin, methods of making it, and pharmaceutical compositions containing it. Also described are methods of converting amorphous rifaximin to crystalline rifaximin and vice versa.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: August 2, 2016
    Assignee: Cipla Ltd.
    Inventors: Dharmaraj Ramachandra Rao, Rajendra Narayanrao Kankan, Manjinder Singh Phull, Maruti Ghagare
  • Patent number: 8178712
    Abstract: The present invention relates to an improved process for the synthesis of Ibandronate sodium of formula (I). The present invention also provides novel processes for the synthesis of 3-[N-(methylpentyl)amino]propionic acid (III).
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: May 15, 2012
    Assignee: Cipla Ltd.
    Inventors: Dharamaraj Ramchandra Rao, Rajendra Narayanrao Kankan, Maruti Ganpati Ghagare
  • Publication number: 20100228052
    Abstract: The present invention relates to an improved process for the synthesis of Ibandronate sodium of formula (I). The present invention also provides novel processes for the synthesis of 3-[N-(methylpentyl)amino]propionic acid (III).
    Type: Application
    Filed: June 22, 2007
    Publication date: September 9, 2010
    Applicant: CIPLA LTD.
    Inventors: Dharamaraj Ramchandra Rao, Rajendra Narayanrao Kankan, Maruti Ganpati Ghagare
  • Publication number: 20100190797
    Abstract: Disclosed are processes for the preparation of crystalline polymorphic forms of zopiclone and their pharmaceutical compositions for use as a sedative.
    Type: Application
    Filed: December 10, 2008
    Publication date: July 29, 2010
    Applicant: CIPLA LTD.
    Inventors: Dharmaraj Ramchandra Rao, Rajendra Narayanrao Kankan, Maruti Ganpati Ghaghare, Sunilkumar Saroj
  • Publication number: 20060035874
    Abstract: This invention relates to pharmaceutical products and compositions for use in the treatment of asthma and related disorders, and especially but not exclusively for the treatment of chronic obstructive pulmonary disease (COPD). More particularly, the invention provides pharmaceutical products and compositions comprising specific anticholinergic agents, ?-2 agonists and corticosteroids.
    Type: Application
    Filed: August 29, 2003
    Publication date: February 16, 2006
    Applicant: CIPLA LTD.
    Inventors: Amar Lulla, Geena Malhotra